RISE Life Science Corp. announced that Greg Mills, formerly Head of RBC's Global Equities, has been appointed to RISE's Board of Directors. During his tenure at RBC, Mr. Mills served on numerous RBC Capital Market Committees including Operating Committee, Pension Investment Sub-Committee, Risk Committee and Diversity Committee. Mr. Mills also serves as Chairman of Aequitas Innovations and is an Associate on the University of Toronto's Creative Destructive Lab.